249 related articles for article (PubMed ID: 17508356)
1. Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function.
Samanna V; Ma T; Mak TW; Rogers M; Chellaiah MA
J Cell Physiol; 2007 Dec; 213(3):710-20. PubMed ID: 17508356
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9.
Spessotto P; Rossi FM; Degan M; Di Francia R; Perris R; Colombatti A; Gattei V
J Cell Biol; 2002 Sep; 158(6):1133-44. PubMed ID: 12235127
[TBL] [Abstract][Full Text] [Related]
3. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2003 Aug; 18(8):1404-18. PubMed ID: 12929930
[TBL] [Abstract][Full Text] [Related]
4. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility.
Chellaiah MA; Hruska KA
Calcif Tissue Int; 2003 Mar; 72(3):197-205. PubMed ID: 12469249
[TBL] [Abstract][Full Text] [Related]
5. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
[TBL] [Abstract][Full Text] [Related]
6. CD44 deficiency inhibits unloading-induced cortical bone loss through downregulation of osteoclast activity.
Li Y; Zhong G; Sun W; Zhao C; Zhang P; Song J; Zhao D; Jin X; Li Q; Ling S; Li Y
Sci Rep; 2015 Nov; 5():16124. PubMed ID: 26530337
[TBL] [Abstract][Full Text] [Related]
7. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
El Hajj Dib I; Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
Eur J Pharmacol; 2006 Dec; 551(1-3):27-33. PubMed ID: 17049513
[TBL] [Abstract][Full Text] [Related]
9. A selective inhibitor of matrix metalloproteinases inhibits the migration of isolated osteoclasts by increasing the life span of podosomes.
Goto T; Maeda H; Tanaka T
J Bone Miner Metab; 2002; 20(2):98-105. PubMed ID: 11862531
[TBL] [Abstract][Full Text] [Related]
10. Interstitial collagenase activity stimulates the formation of actin rings and ruffled membranes in mouse marrow osteoclasts.
Holliday LS; Welgus HG; Hanna J; Lee BS; Lu M; Jeffrey JJ; Gluck SL
Calcif Tissue Int; 2003 Mar; 72(3):206-14. PubMed ID: 12522662
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
[TBL] [Abstract][Full Text] [Related]
12. Filamin A regulates monocyte migration through Rho small GTPases during osteoclastogenesis.
Leung R; Wang Y; Cuddy K; Sun C; Magalhaes J; Grynpas M; Glogauer M
J Bone Miner Res; 2010 May; 25(5):1077-91. PubMed ID: 19929439
[TBL] [Abstract][Full Text] [Related]
13. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation.
de Vries TJ; Schoenmaker T; Beertsen W; van der Neut R; Everts V
J Cell Biochem; 2005 Apr; 94(5):954-66. PubMed ID: 15578568
[TBL] [Abstract][Full Text] [Related]
14. Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.
Neutzsky-Wulff AV; Sørensen MG; Kocijancic D; Leeming DJ; Dziegiel MH; Karsdal MA; Henriksen K
BMC Musculoskelet Disord; 2010 Jun; 11():109. PubMed ID: 20515459
[TBL] [Abstract][Full Text] [Related]
15. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
16. Transmigration: a new property of mature multinucleated osteoclasts.
Saltel F; Chabadel A; Zhao Y; Lafage-Proust MH; Clézardin P; Jurdic P; Bonnelye E
J Bone Miner Res; 2006 Dec; 21(12):1913-23. PubMed ID: 17002556
[TBL] [Abstract][Full Text] [Related]
17. Membrane localization of membrane type 1 matrix metalloproteinase by CD44 regulates the activation of pro-matrix metalloproteinase 9 in osteoclasts.
Chellaiah MA; Ma T
Biomed Res Int; 2013; 2013():302392. PubMed ID: 23984338
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.
Hussein O; Tiedemann K; Komarova SV
Bone; 2011 Feb; 48(2):202-11. PubMed ID: 20849994
[TBL] [Abstract][Full Text] [Related]
19. Azithromycin suppresses human osteoclast formation and activity in vitro.
Gannon SC; Cantley MD; Haynes DR; Hirsch R; Bartold PM
J Cell Physiol; 2013 May; 228(5):1098-107. PubMed ID: 23065774
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts.
Yun JH; Pang EK; Kim CS; Yoo YJ; Cho KS; Chai JK; Kim CK; Choi SH
J Periodontal Res; 2004 Oct; 39(5):300-7. PubMed ID: 15324350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]